Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Signe Schmidt

Showing results (11-20 of 73) with videos related to

Pageof 8
Sort By:
Diabetologia|April 10, 2023
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trialChristian Laugesen, Ajenthen G Ranjan, Signe Schmidt, et al.
Journal of Diabetes Science and Technology|October 17, 2024
GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World StudyPernille Holmager, Merete Bechmann Christensen, Kirsten Nørgaard, et al.
Diabetes Research and Clinical Practice|June 2, 2017
Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate countingSigne Schmidt, Dorte Vistisen, Thomas Almdal, et al.
Trends in Endocrinology and Metabolism: TEM|March 20, 2026
Exercise timing and circadian regulation of metabolism in type 2 diabetesSigne Schmidt Kjølner Hansen, Juleen R Zierath, Harriet Wallberg-Henriksson
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 2010
Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancyAnna L Secher, Signe Schmidt, Kirsten Nørgaard, et al.
Diabetes Technology & Therapeutics|September 28, 2019
Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor SiteChristian Laugesen, Signe Schmidt, Rikke Tetzschner, et al.
Ugeskrift for Laeger|October 28, 2022
Sten Madsbad, Mikkel Wiberg, Luma Mahmoud Issa, et al.
BMJ Open Diabetes Research & Care|January 29, 2021
Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetesIsabelle Isa Kristin Steineck, Ajenthen G Ranjan, Signe Schmidt, et al.
Diabetes, Obesity & Metabolism|December 18, 2020
The effect of preceding glucose decline rate on low-dose glucagon efficacy in individuals with type 1 diabetes: A randomized crossover trialChristian Laugesen, Signe Schmidt, Jens Juul Holst, et al.
Diabetes/Metabolism Research and Reviews|October 3, 2020
Education programmes for persons with type 1 diabetes using an insulin pump: A systematic reviewKaren Rytter, Signe Schmidt, Lauge Neimann Rasmussen, et al.
Pageof 8

Showing results (11-20 of 73) with videos related to

Sort By:
Pageof 8
Diabetologia|April 10, 2023
Pen-administered low-dose dasiglucagon vs usual care for prevention and treatment of non-severe hypoglycaemia in people with type 1 diabetes during free-living conditions: a Phase II, randomised, open-label, two-period crossover trialChristian Laugesen, Ajenthen G Ranjan, Signe Schmidt, et al.
Journal of Diabetes Science and Technology|October 17, 2024
GLP-1 Receptor Agonists in Overweight and Obese Individuals With Type 1 Diabetes Using an Automated Insulin Delivery Device: A Real-World StudyPernille Holmager, Merete Bechmann Christensen, Kirsten Nørgaard, et al.
Diabetes Research and Clinical Practice|June 2, 2017
Exploring factors influencing HbA1c and psychosocial outcomes in people with type 1 diabetes after training in advanced carbohydrate countingSigne Schmidt, Dorte Vistisen, Thomas Almdal, et al.
Trends in Endocrinology and Metabolism: TEM|March 20, 2026
Exercise timing and circadian regulation of metabolism in type 2 diabetesSigne Schmidt Kjølner Hansen, Juleen R Zierath, Harriet Wallberg-Henriksson
Acta Obstetricia Et Gynecologica Scandinavica|September 1, 2010
Continuous glucose monitoring-enabled insulin-pump therapy in diabetic pregnancyAnna L Secher, Signe Schmidt, Kirsten Nørgaard, et al.
Diabetes Technology & Therapeutics|September 28, 2019
Glucose Sensor Accuracy After Subcutaneous Glucagon Injections Near to Sensor SiteChristian Laugesen, Signe Schmidt, Rikke Tetzschner, et al.
Ugeskrift for Laeger|October 28, 2022
Sten Madsbad, Mikkel Wiberg, Luma Mahmoud Issa, et al.
BMJ Open Diabetes Research & Care|January 29, 2021
Time spent in hypoglycemia is comparable when the same amount of exercise is performed 5 or 2 days weekly: a randomized crossover study in people with type 1 diabetesIsabelle Isa Kristin Steineck, Ajenthen G Ranjan, Signe Schmidt, et al.
Diabetes, Obesity & Metabolism|December 18, 2020
The effect of preceding glucose decline rate on low-dose glucagon efficacy in individuals with type 1 diabetes: A randomized crossover trialChristian Laugesen, Signe Schmidt, Jens Juul Holst, et al.
Diabetes/Metabolism Research and Reviews|October 3, 2020
Education programmes for persons with type 1 diabetes using an insulin pump: A systematic reviewKaren Rytter, Signe Schmidt, Lauge Neimann Rasmussen, et al.
Pageof 8